Collaborate, share, and expand knowledge and practice with neuroendocrinology leaders in the scientific, clinical, and translational arenas. SIG leaders plan to connect researchers and clinicians for a better understanding of research needs, leverage the Society’s unique position to act as a convening space for neuroendocrinology leaders, and develop resources for early career researchers and principal investigators in neuroendocrinology. Participate in educational, networking, and engagement activities, including webinars, event meetups, collaborative projects, and more.
Upcoming Webinar: Entrepreneurship and Neuroendocrinology SIGs Joint Webinar: The Long Academic Journey to Commercialization
Date: October 15, 2025 Time: 12:00 PM ET
Moderator: Professor Denise Belsham, University of Toronto
Speakers: Professor Deborah Kurrasch, University of Calgary
Description:
The role of the academic researcher has evolved over time. Now researchers are encouraged to translate their basic research findings to commercially viable solutions for health with economically beneficial terms. Join the Entrepreneurship and Neuroendocrinology SIGs from 12:00–1:00 PM ET on Wednesday, October 15 for this joint webinar taking the audience through a specific academic journey from discovery to disclosure of intellectual property to starting a viable biotech company. The highs and lows of the process will be discussed with valuable advice on how to bring your research to the market.
Learning Objectives:
Objective 1 - Understanding bench to bedside research
Objective 2 – The steps to start a biotech company from an academic discovery
Objective 3 – Advice on how to start this exciting journey to commercialization
Translating KNDy Neuron Biology into New Therapies
Date: Wednesday, April 30, 2025 Time: 12:00 PM ET (5:00 PM UK)
Moderators:
Denise Belsham, PhD, University of Toronto
Michael Lehman, PhD, Kent State University
Speaker:
Waljit Dhillo, FRCP, FMedSci, Imperial College London
Description:
Neurones which co-express Kisspeptin, neurokinin B and dynorphin (KNDy neurones) are the master regulators of GnRH secretion in the control of reproductive function. This webinar will highlight how translating these discovery science findings in humans has led to potential new treatments for patients with reproductive disorders.
Learning Objectives:
Objective 1: KNDy neurons are the master regulator of GnRH secretion
Objective 2: Kisspeptin stimulates GnRH secretion and has potential as a novel treatment for patients with reproductive disorders
Objective 3: Neurokinin B acting via the NK3 receptor mediates vasomotor symptoms in post-menopausal women and hence NK3R antagonists are a new target for treating this condition
Collaborate, share, and expand knowledge and practice with neuroendocrinology leaders in the scientific, clinical, and translational arenas. SIG leaders plan to connect researchers and clinicians for a better understanding of research needs, leverage the Society’s unique position to act as a convening space for neuroendocrinology leaders, and develop resources for early career researchers and principal investigators in neuroendocrinology. Participate in educational, networking, and engagement activities, including webinars, event meetups, collaborative projects, and more.
